EMEA-000645-PIP04-20
Key facts
Invented name |
Entyvio
|
Active substance |
vedolizumab
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0186/2021
|
PIP number |
EMEA-000645-PIP04-20
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of pouchitis
|
Route(s) of administration |
|
Contact for public enquiries |
Takeda Pharma A/S
E-mail: paediatrics@tgrd.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|